Scientific Advances

Selected recent research findings from DCTD programs.

Cancer Therapy Evaluation Program

• Improving Outcome for Children with High-Risk Neuroblastoma
• High Dose Chemotherapy Significantly Prolongs Survival for Patients with Acute Myeloid Leukemia
• Lenalidomide for Multiple Myeloma Demonstrated to Significantly Extend Progression-Free Survival
• Disease-Free Breast Cancer Survival Improves When Herceptin is Used With Chemotherapy
• Childhood Cancer TARGET Initiative Acute Lymphoblastic Leukemia Discoveries

Cancer Diagnosis Program

• CDP Activities on Profiling of Immune Response for Cancer Diagnosis, Prognosis, and Treatment
• Director’s Challenge Lung Study
• Adolescent and Young Adult Cancer
• Circulating Tumor Cells: Moving New Technologies to the Clinic
• Cancer Stem Cell Workshop
• Use of Omics predictors in clinical trials workshop, June 2011
• Global Diagnostics Conference, August 2011
• Cancer Detection and Diagnostics Technologies for Global Health Conference, August 2011

Cancer Imaging Program

• Results of Selected ACRIN Clinical Trials
• Scientific Advances from selected CIP Grantees

Developmental Therapeutics Program

• Romidepsin (Istodax®, FR228 and FR901228)
• Eribulin (Halaven®; E-7389)
• Sipuleucel-T (Provenge®)
• Ch14.18 Monoclonal Antibody

Radiation Research Program

• Selected Advances

Translational Research Program

• Selected Translational Research Advances for Various Cancer Types

Biometric Research Branch

• Selected Scientific Advances Contributed by Staff Members